Real-world data platform Atropos Health announced it appointed a life science advisory board and moved into the life sciences sector, offering AI innovations, data evaluation, evidence generation and analytics augmentation.
Atropos' app helps physicians access real-world evidence to guide clinical decisions and research.
The California-based company also offers its Green Button for clinical...
Kakao Healthcare, the digital healthcare business of South Korean internet company Kakao Corporation, has partnered with Novo Nordisk to further develop its diabetes management service powered by mobile and AI technologies.
The two organisations recently signed a memorandum of understanding to launch a smart healthcare service to support patients with diabetes. According to a press release, Kakao...
FeelBetter, a machine learning-enabled medication-management platform focused on polypharmacy, announced it secured $5.9 million in funding led by Firstime Ventures and Shoni Health Ventures.
Random Forest VC, The Group Ventures, and existing FeelBetter investor Triventures also participated in the round.
The latest round brings the company's total raise to $8 million.
WHAT IT DOES
FeelBetter...
Duopharma Biotech, one of Malaysia's biggest pharmaceutical companies, has committed to expanding access to a mobile breast cancer screening device at the community level.
It has signed a distribution deal with the Malaysian unit of US-based femtech company UE LifeSciences to make the iBreastExam device available in primary care clinics across the country.
iBreastExam is a hand-held, radiation-...
Causaly, a tech company using AI to interpret large datasets and literature, announced it closed a $60 million Series B round led by ICONIQ Growth.
Marathon Venture Capital, Index Ventures, Pentech Ventures, EBRD and Visionaries Club also participated in the round, as did former chairman and CEO of Johnson & Johnson Alex Gorsky and CEO and cofounder of Datadog Olivier Pomel.
WHAT IT DOES...
CVS Caremark, a pharmacy benefit manager and part of CVS Health, announced it is partnering with drug cost and telehealth company GoodRx to launch Caremark Cost Saver, providing Caremark's members access to GoodRx's lower-cost prescription pricing.
Beginning January 1, 2024, Caremark's members can use their existing benefit card at an in-network pharmacy of their choice to automatically have...
Mark Cuban Cost Plus Drug Company (MCCPDC) has announced a partnership with male fertility and sexual healthcare company Posterity Health to provide males access to medications to treat infertility, sexual dysfunction and low testosterone.
Posterity Health is a digital male fertility clinic providing access to reproductive urologists who diagnose and treat sexual health and male fertility issues...
Mark Cuban Cost Plus Drug Company (MCCPDC) announced that it's working with Coherus Biosciences to sell Yusimry, a biosimilar version of the top-selling drug Humira, at a discounted price.
Yusimry is used to treat several diseases, such as rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, ulcerative colitis, hidradenitis suppurativa, Crohn’s...
Healthcare data company ConcertAI announced its expanded partnership with Caris Life Sciences, where the companies will jointly create a database to generate insights to advance precision medicine, clinical trial management and therapeutic development.
ConcertAI is a real-world data and AI company for healthcare providers and life science companies, while Caris Life Sciences offers whole exome...
The Michael J. Fox Foundation (MJFF) has announced a partnership with New York-based H1, a healthcare data company, to streamline its search for physicians actively treating Parkinson's disease patients and gather information on patient populations and treatment approaches.
MJFF will utilize H1's Trial Landscape, an AI-enabled platform that uses performance data to gain insights into clinical...
_164d6.jpg "Mark Cuban, cofounder of Mark Cuban Cost Plus Drug Company")
